Module content:
· Historical basis of mutagenicity testing
· Diversity of methods ranging from the use of viruses to whole animals
· Information sources on the methods that are available in the literature
· Basic principles behind genetic toxicology
· Role and place of test methods in compound development
· Selection of the key informative test methods
· The concept of assay sensitivity and specificity
· The international collaborative studies and the range of assays evaluated
· Development and understanding of those methods with appropriate range of qualities and sensitivities for testing and the limitations of many methods
· The handling of published data, limitations e.g. lack of GLP etc
· Assay Validation
· The development of the Bacterial Gene Mutation Assay. Basic battery, specialised strains, e.g. for oxidative damage, cross-linking agents etc
· Modifications, e.g. fluctuation tests
· In vitro cytogenetics, human and rodent cultures
· Basic metaphase analysis, structural and numerical changes, molecular methods, FISH methods, fluorescent probes
· In vitro micronucleus assay, structural numerical changes, centromere and kinetochore staining, binucleate cell assay, measurement of non-disjunction
· In vitro gene mutation assays, HPRT methods, thymidine kinase (TK) mutations
· The value of the mouse lymphoma assay, range of endpoints (chromosome and point mutation
· Experimental design
· The transition from in vitro to in vivo
assessment
, test selections. Factors that may influence the relationships between in vitro and in vivo response
· In vitro methods, bone marrow cytogenetics, bone marrow and peripheral blood micronucleus assays
· Comet assays in vitro and in vivo, tissue specificity, the role of the in vivo/in vitro rat-liver UDS assays. Use of DNA adducts measurements.